Use of erythropoiesis-stimulating agents in the treatment of myelosuppresive chemotherapy-induced anemia has been shown to increase hemoglobin levels and reduce the need for transfusions in patients with cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790673 | PMC |
| http://dx.doi.org/10.1200/JOP.091011 | DOI Listing |
Publication Analysis
Top Keywords
patterns care
4
care community-based
4
community-based oncology
4
oncology practices
4
practices anemia
4
anemia associated
4
associated myelosuppressive
4
myelosuppressive chemotherapy
4
chemotherapy erythropoiesis-stimulating
4
erythropoiesis-stimulating agents
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!